An integrated approach for inference and mechanistic modeling for advancing drug development
- 16 February 2005
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 579 (8) , 1878-1883
- https://doi.org/10.1016/j.febslet.2005.02.012
Abstract
An important challenge facing researchers in drug development is how to translate multi-omic measurements into biological insights that will help advance drugs through the clinic. Computational biology strategies are a promising approach for systematically capturing the effect of a given drug on complex molecular networks and on human physiology. This article discusses a two-pronged strategy for inferring biological interactions from large-scale multi-omic measurements and accounting for known biology via mechanistic dynamical simulations of pathways, cells, and organ- and tissue level models. These approaches are already playing a role in driving drug development by providing a rational and systematic computational framework.Keywords
This publication has 37 references indexed in Scilit:
- How molecular profiling could revolutionize drug discoveryNature Reviews Drug Discovery, 2005
- Bioinformatics—from genes to pathwaysNature Methods, 2004
- A model for restriction point control of the mammalian cell cycleJournal of Theoretical Biology, 2004
- Periodic Signaling Controlled by an Oscillatory Circuit That Includes Protein Kinases ERK2 and PKAScience, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Statistical mechanical approaches to models with many poorly known parametersPhysical Review E, 2003
- Clinical biomarkers in drug discovery and developmentNature Reviews Drug Discovery, 2003
- Modeling the early signaling events mediated by FcεRIMolecular Immunology, 2002
- Computational analysis of microarray dataNature Reviews Genetics, 2001
- Using Bayesian Networks to Analyze Expression DataJournal of Computational Biology, 2000